Modulating Vascular Hemodynamics With an Alpha Globin Mimetic Peptide (HbαX)

Area of Science:

• Cardiovascular Science
• Pharmacology
• Biochemistry

Background:

• Hemoglobin's scavenging of nitric oxide (NO) is crucial for vascular tone homeostasis.
• Endothelial alpha globin and endothelial NO synthase form a complex, regulating NO bioavailability.
• A need exists for targeted modulators of this NO-scavenging pathway.

Purpose of the Study:

• To develop and characterize an alpha globin mimetic peptide (HbαX).
• To investigate HbαX's effects on NO bioavailability, vascular function, and blood pressure in vivo.
• To assess HbαX's specificity, affinity, and safety profile.

Main Methods:

• Development of HbαX, an alpha globin mimetic peptide.
• In vivo administration of HbαX in normal and angiotensin II-induced hypertensive models.
• Measurement of capillary oxygenation, blood flow, and systolic blood pressure.
• Assessment of HbαX binding to endothelial NO synthase and effects on O2 binding in red blood cells.
• Evaluation of vasoconstrictive responses in human vasculature.

Main Results:

• HbαX administration increased capillary oxygenation and arteriolar blood flow acutely.
• Sustained decrease in systolic blood pressure observed in both normal and hypertensive states.
• HbαX demonstrated high specificity and affinity for endothelial NO synthase.
• No observed toxicity in liver and kidney; no effect on red blood cell O2 binding.
• HbαX blunted vasoconstriction in human vasculature.

Conclusions:

• HbαX effectively modulates vascular function by enhancing NO bioavailability.
• The peptide increases vasodilation and blood flow in the resistance vasculature.
• HbαX represents a promising therapeutic agent for managing vascular tone and blood pressure.